false 0001113232 0001113232 2025-02-10 2025-02-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 10, 2025

 

Axcelis Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   000-30941   34-1818596
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)

 

108 Cherry Hill Drive, Beverly, Massachusetts   01915
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (978) 787-4000

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.001 per share ACLS NASDAQ Global Select Market

 

 

 

 

 

Item 2.02 Results of Operations and Financial Condition

 

On February 10, 2025, Axcelis Technologies, Inc. (the “Company”) issued a press release regarding its financial results for its quarter and year ended December 31, 2024. The Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.   Description
     
99.1   Press Release dated February 10, 2025. Filed herewith
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: February 10, 2025 Axcelis Technologies, Inc.
   
  By: /s/ James Coogan
    James Coogan
    Executive Vice President
    and Chief Financial Officer

 

 

3

 

Exhibit 99.1

 

 

 

Axcelis Announces Financial Results for Fourth Quarter and Full Year 2024

 

Q4 Highlights:

 

·Revenue of $252.4 million
·Operating Margin of 21.6%
·Diluted earnings per share of $1.54

 

BEVERLY, Mass.— Feb. 10, 2025—Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2024.

 

For the full year 2024, the Company reported revenue of $1.02 billion, compared with $1.13 billion for the full year 2023. Systems revenue for the year was $782.6 million, compared to $883.6 million in 2023. Operating profit was $210.8 million in 2024, compared to $265.8 million in 2023. Net income for the year was $201 million with diluted earnings per share of $6.15, compared to net income of $246.3 million and diluted earnings per share of $7.43 in 2023. Gross margin for the year was 44.7%, compared to 43.5% in 2023.

 

The Company reported fourth quarter revenue of $252.4 million, compared to $256.6 million for the third quarter of 2024. Gross margin for the quarter was 46.0%, compared to 42.9% in the third quarter. Operating profit for the quarter was $54.5 million, compared to $46.9 million for the third quarter. Net income for the quarter was $50 million, or $1.54 per diluted share, compared to $48.6 million, or $1.49 per diluted share in the third quarter.

 

President and CEO Russell Low commented, “Axcelis exited the year on a strong note, with fourth quarter revenue and profitability exceeding our expectations. As we look ahead to 2025, we anticipate a near term cyclical digestion period, as customers absorb the robust investments they’ve made into mature node capacity over the past few years – particularly in China. We are focused on capturing the long-term growth opportunities that lie ahead by investing in product innovation, managing our costs, and working closely with customers on their technology roadmaps – all of which will put us in an even stronger position for the next upturn.”

 

Executive Vice President and Chief Financial Officer Jamie Coogan said, “We are pleased with our financial execution in 2024. Despite a decline in revenue, we were able to deliver higher gross margins, generate solid free cash flow, return capital to shareholders via buyback, and exit the year with a stronger balance sheet that allows us to invest during this cyclical digestion period and drive long term value creation.”

 

 

 

 

 

 

Business Outlook

 

For the first quarter ending March 31, 2025, Axcelis expects revenues of approximately $185 million, and earnings per diluted share of approximately $0.38.

 

Fourth Quarter and Full Year 2024 Conference Call

 

The Company will host a call to discuss the results for the fourth quarter and full year 2024 on Tuesday, February 11, 2025, at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here:

 

https://register.vevent.com/register/BIb4b94bbc1cf744869eeb20b9a9be88a7
Webcast replays will be available for 30 days following the call.

 

Safe Harbor Statement

 

This press release and the conference call contain forward-looking statements under the Private Securities Litigation Reform Act safe harbor provisions. These statements, which include our expectations for spending in our industry and guidance for future financial performance, are based on management’s current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are outside the control of the Company, including that customer decisions to place orders or our product shipments may not occur when we expect, that orders may not be converted to revenue in any particular quarter, or at all, whether demand will continue for the semiconductor equipment we produce or, if not, whether we can successfully meet changing market requirements, and whether we will be able to maintain continuity of business relationships with and purchases by major customers. Increased competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and instability caused by changing global economic, political or financial conditions could also cause actual results to differ materially from those in our forward-looking statements. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.

 

About Axcelis:

 

Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 45 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

 

 

 

 

 

 

CONTACTS:

 

Investor Relations Contact:

David Ryzhik

Senior Vice President, Investor Relations and Corporate Strategy

Telephone: (978) 787-2352

Email: David.Ryzhik@axcelis.com

 

Press/Media Relations Contact:

Maureen Hart

Senior Director, Corporate & Marketing Communications

Telephone: (978) 787-4266

Email: Maureen.Hart@axcelis.com

 

 

 

 

 

 

Axcelis Technologies, Inc.

Consolidated Statements of Operations

(In thousands, except per share amounts)

(Unaudited)

 

   Three months ended   Twelve months ended 
   December 31,   December 31, 
   2024   2023   2024   2023 
Revenue:                
Product  $241,254   $300,603   $976,881   $1,095,650 
Services   11,163    9,685    40,984    34,954 
Total revenue   252,417    310,288    1,017,865    1,130,604 
Cost of revenue:                    
Product   125,402    163,801    524,451    608,112 
Services   10,792    8,591    38,760    31,191 
Total cost of revenue   136,194    172,392    563,211    639,303 
Gross profit   116,223    137,896    454,654    491,301 
Operating expenses:                    
Research and development   27,654    24,911    105,497    96, 907 
Sales and marketing   16,563    16,659    68,046    62,805 
General and administrative   17,475    17,275    70,317    65,794 
Total operating expenses   61,692    58,845    243,860    225,506 
Income from operations   54,531    79,051    210,794    265,795 
Other income (expense):                    
Interest income   6,277    5,375    24,403    18,199 
Interest expense   (1,444)   (1,320)   (5,462)   (5,347)
Other, net   (719)   4,300    539    (48)
Total other income   4,114    8,355    19,480    12,804 
Income before income taxes   58,645    87,406    230,274    278,599 
Income tax provision   8,689    16,350    29,282    32,336 
Net income  $49,956   $71,056   $200,992   $246,263 
Net income per share:                    
Basic  $1.54   $2.17   $6.17   $7.52 
Diluted  $1.54   $2.15   $6.15   $7.43 
Shares used in computing net income per share:                    
Basic weighted average shares of common stock   32,424    32,708    32,552    32,758 
Diluted weighted average shares of common stock   32,514    33,031    32,704    33,165 

 

 

 

 

 

 

Axcelis Technologies, Inc.

Consolidated Balance Sheets

(In thousands, except per share amounts)

(Unaudited)

 

         
   December 31,   December 31, 
   2024   2023 
ASSETS
Current assets:          
Cash and cash equivalents  $123,512   $167,297 
Short-term investments   447,831    338,851 
Accounts receivable, net   203,149    217,964 
Inventories, net   282,225    306,482 
Prepaid income taxes   6,420     
Prepaid expenses and other current assets   60,471    49,397 
Total current assets   1,123,608    1,079,991 
Property, plant and equipment, net   53,784    53,971 
Operating lease assets   29,621    30,716 
Finance lease assets, net   15,346    16,632 
Long-term restricted cash   7,552    6,654 
Deferred income taxes   68,277    53,428 
Other assets   50,593    40,575 
Total assets  $1,348,781   $1,281,967 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:          
Accounts payable  $46,928   $54,400 
Accrued compensation   25,536    31,445 
Warranty   13,022    14,098 
Income taxes       6,164 
Deferred revenue   94,673    164,677 
Current portion of finance lease obligation   1,345    1,511 
Other current liabilities   26,018    12,834 
Total current liabilities   207,522    285,129 
Long-term finance lease obligation   42,329    43,674 
Long-term deferred revenue   43,501    46,208 
Other long-term liabilities   42,639    42,074 
Total liabilities   335,991    417,085 
           
Stockholders’ equity:          
Common stock, $0.001 par value, 75,000 shares authorized; 32,365 shares issued and outstanding at December 31, 2024; 32,685 shares issued and outstanding at December 31, 2023   32    33 
Additional paid-in capital   548,654    547,189 
Retained earnings   470,318    319,506 
Accumulated other comprehensive loss   (6,214)   (1,846)
Total stockholders’ equity   1,012,790    864,882 
Total liabilities and stockholders’ equity  $1,348,781   $1,281,967 

 

 

 

 

 

 

Axcelis Technologies, Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

   Three months ended   Twelve months ended 
   December 31,   December 31, 
   2024   2023   2024   2023 
Cash flows from operating activities                    
Net income  $49,956   $71,056   $200,992   $246,263 
Adjustments to reconcile net income to net cash provided by operating activities:                    
Depreciation and amortization   4,267    3,581    15,809    13,069 
Stock-based compensation expense   5,380    5,239    20,951    18,269 
Other   (442)   (14,565)   (11,532)   (23,503)
Change in operating assets and liabilities, net   (46,381)   264    (85,402)   (97,229)
Net cash provided by operating activities   12,780    65,575    140,818    156,869 
                     
Cash flows from investing activities                    
Expenditures for property, plant and equipment and capitalized software   (4,658)   (10,153)   (12,181)   (20,656)
Other changes in investing activities, net   13,779    (16,526)   (96,545)   (80,202)
Net cash provided by (used in) investing activities   9,121    (26,679)   (108,726)   (100,858)
                     
Cash flows from financing activities                    
Repurchase of common stock   (15,131)   (15,001)   (60,489)   (52,499)
Other changes from financing activities, net   588    (22)   (10,703)   (15,769)
Net cash used in financing activities   (14,543)   (15,023)   (71,192)   (68,268)
                     
Effect of exchange rate changes on cash and cash equivalents   (3,013)   1,128    (3,787)   (139)
Net increase (decrease) in cash, cash equivalents and restricted cash   4,345    25,001    (42,887)   (12,396)
                     
Cash, cash equivalents and restricted cash at end of period  $131,064   $173,951   $131,064   $173,951 

 

 

 

v3.25.0.1
Cover
Feb. 10, 2025
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Feb. 10, 2025
Entity File Number 000-30941
Entity Registrant Name Axcelis Technologies, Inc.
Entity Central Index Key 0001113232
Entity Tax Identification Number 34-1818596
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 108 Cherry Hill Drive
Entity Address, City or Town Beverly
Entity Address, State or Province MA
Entity Address, Postal Zip Code 01915
City Area Code 978
Local Phone Number 787-4000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol ACLS
Security Exchange Name NASDAQ
Entity Emerging Growth Company false

Axcelis Technologies (NASDAQ:ACLS)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Axcelis Technologies Charts.
Axcelis Technologies (NASDAQ:ACLS)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Axcelis Technologies Charts.